Redesigning for speed: Addressing life cycle compression in biopharma - McKinsey

Retrieved on: 2024-03-14 17:25:58

Tags for this article:

Actuarial science

Inflation

Irish Republican Army

Risk

Click the tags to see associated articles and topics

Redesigning for speed: Addressing life cycle compression in biopharma - McKinsey. View article details on hiswai:

Summary

The article addresses challenges in the biopharma industry, including risk mitigation and the impact of U.S. Inflation Reduction Act (IRA) on drug life cycles, without direct relevance to actuarial science or the Irish Republican Army.

Article found on: www.mckinsey.com

View Original Article